Daiichi, Forest Reach $300M Settlement In Benicar MDL
By Jeannie O'Sullivan (August 1, 2017, 11:30 AM EDT) -- Daiichi Sankyo Inc. and Forest Laboratories Inc. have agreed to pay $300 million to settle claims in state and federal courts that the blood pressure drug Benicar caused gastrointestinal injuries, lawyers for both sides announced Tuesday.
Benicar manufacturer Daiichi Sankyo Inc. and Forest Laboratories Inc. agreed Tuesday to pay $300 million to settle suits that claimed the drug was designed in a defective manner. (Getty)
Both sides signed a master settlement agreement Tuesday morning, prior to the conference before U.S. District Judge Robert B. Kugler in New Jersey federal court in Camden.
Daiichi Sankyo hasn't admitted to any liability and believes...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!